Detect Hereditary Prostate Cancer

Sponsored, no-charge genetic testing and counseling for hereditary prostate cancer

Start an order

The Detect Hereditary Prostate Cancer program provides no-charge genetic testing and counseling for individuals diagnosed with prostate cancer, stage II and above.

About prostate cancer

  • Prostate cancer is the leading cancer in males in the US. An estimated 174,000 new cases are diagnosed each year.

  • Up to 10% of patients with metastatic or advanced prostate cancer and 3% of patients with localized prostate cancer carry a disease-causing variant in a DNA repair gene and other genes conferring risk for hereditary cancer disorders.

  • Determining the germline genetic etiology of prostate cancer provides eligibility for precision medical and surgical treatment options and eligibility to participate in clinical treatment trials. It enables surveillance for, and early detection of, other DNA repair-related cancers, and identification of risk and surveillance recommendations for early detection in at-risk relatives.


Learn more

Ordering instructions

Learn more

Program eligibility

This program is available to males in the US and Canada with one of the following diagnoses:

  • Risk group Intermediate/High/Very High (stages III or IV prostate cancer) at any age
  • Risk group Low (stage II prostate cancer) and under 55 years of age
  • Stage undetermined but suspected Low risk (stage II) or above at any age

Genetic testing with Invitae

The Detect Hereditary Prostate Cancer program offers testing with the Invitae Multi-Cancer Panel, a comprehensive cancer panel that tests genes associated with hereditary cancer syndromes, including all known prostate cancer genes.

View panel

Genetic counseling

Individuals tested through the Detect Hereditary Prostate Cancer program will be eligible for no-charge, post-test genetic counseling to help them understand their test results. Invitae's genetic counseling services include:

  • Review of the patient's medical history and family history.
  • Review of the patient’s genetic test results and the implications of those results for the patient and their family.
  • A detailed consult note and pedigree made available to the patient and clinician after the genetic counseling session is complete.

Learn more

Place your order

To collect a specimen:

  1. Order a specimen collection kit
  2. Label the sample tube with the patient’s full name, date of birth, and sample collection date
  3. For additional information, please see specimen and shipping requirements
  4. Include the paper order form with your sample

To receive results:

  1. Once Invitae receives the sample, you will receive the results in 10 to 21 calendar days, on average
  2. If you created an online account, you can view the status of your order by logging into your account
  3. You will receive a notification email once the test results are ready

Please note that the Detect Hereditary Prostate Cancer program only accepts paper orders.

Support every step of the way

Invitae is available to answer your questions or help you through the testing process.


Confidence begins with quality

  • Commitment to quality: Invitae’s >1000 patient peer-reviewed study, published in the Journal Molecular Diagnostics, the official journal of the Association for Molecular Pathology, shows equivalence to established standards.
  • Sample options: blood and saliva kits provided free of charge.
  • Strong team: Invitae has more than 300 experts in genetics, bioinformatics, engineering, technology, and commercial development.

About Invitae

Invitae is a genetic information company whose mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae provides clinical-grade, medically actionable genetic information to answer essential health questions across all stages of life.


While third parties and commercial organizations may provide financial support for this program, tests and services are performed by Invitae. Healthcare professionals must confirm that patients meet certain criteria to use the program. Third parties and commercial organizations may receive de-identified patient data from this program, but at no time would they receive patient identifiable information. Third parties and commercial organizations may receive contact information for healthcare professionals who use this program. Genetic testing and counseling are available in the US and Canada. Healthcare professionals and patients who participate in this program have no obligation to recommend, purchase, order, prescribe, promote, administer, use or support any other products or services from Invitae or from third parties or commercial organizations.